clinicaltrialsarena1h
New breast cancer treatment method sees success in New York trial
The Phase I trial of the combination therapy saw a an approximate 66% rate of near-complete remission in its cohort of breast ...
clinicaltrialsarena2h
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.
clinicaltrialsarena13h
Radiopharmaceutical trials face extra complexities due to nuclear red tape
As more companies are investigating radiopharmaceuticals, the complexities and red tape faced by sponsors are becoming more ...
clinicaltrialsarena23h
Shuttle Pharma announces glioblastoma trial expansion
As the first cohort of patients are dosed in the Phase II trial, multiple new trial sites are added for the glioblastoma ...